FDA reports on the shortage of intravenous (IV) solutions


#IVTEAM #Intravenous news: FDA report “FDA is aware of the shortage situation for intravenous (IV) solutions, particularly 0.9% sodium chloride injection (i.e., saline) used to provide patients with the necessary fluids for hydration and other conditions. The shortage has been triggered by a range of factors including a reported increased demand by hospitals, potentially related to the flu season.

We are working with the three manufacturers of these products, Baxter Healthcare Corp., B.Braun Medical Inc., and Hospira Inc., to help preserve the supply of these necessary products. Addressing this shortage will depend on the increased demand and the manufacturing production of the current suppliers. Millions of these I.V. solutions are used each week by health care professionals.”

Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).

Main page


Comments are closed.